HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantification of osteopontin in the urine of healthy and stone-forming men.

Abstract
Osteopontin (OPN) is one of the most important components in calcium stone matrix, but its role in stone formation is not clear. Since quantitative data regarding the excretion of OPN are necessary to assess its role, we have developed a quantitative enzyme-linked immunosorbent assay (ELISA) for OPN, and measured the urinary OPN concentrations in urolithiasis patients. Forty-seven men with urinary stones composed chiefly of calcium oxalate participated in the study. The controls were 13 normal healthy male volunteers. Urine samples were collected early in the morning and analyzed by a quantitative ELISA employing purified polyclonal antibodies to synthesized OPN aminopolypeptides. The urinary ratio of the concentrations of OPN and creatinine (OPN/Cre) in the urolithiasis patients (0.039 +/- 0.029) was significantly lower than that in the control subjects (0.062 +/- 0.030) (P<0.05). Single stone formers (n = 26; 0.050 +/- 0.020) had significantly higher OPN/Cre ratios compared with recurrent stone formers (n = 21; 0.031 +/- 0.021) (P<0. 05). The results show that OPN excretion in urolithiasis patients was lowered, presumably because of the incorporation of OPN by kidney stones.
AuthorsT Yasui, K Fujita, Y Hayashi, K Ueda, S Kon, M Maeda, T Uede, K Kohri
JournalUrological research (Urol Res) Vol. 27 Issue 4 Pg. 225-30 (Aug 1999) ISSN: 0300-5623 [Print] Germany
PMID10460890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • SPP1 protein, human
  • Sialoglycoproteins
  • Osteopontin
  • Creatinine
  • Calcium
Topics
  • Adult
  • Aged
  • Calcium (urine)
  • Creatinine (urine)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Osteopontin
  • Recurrence
  • Reference Values
  • Sialoglycoproteins (urine)
  • Urinary Calculi (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: